FdaApplication
NDA 022013
Identifiers
- fda_app_no: NDA022013
Properties
| Property | Value |
|---|---|
| applicant_name | QUAGEN PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2007-01-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OLUX E | CLOBETASOL PROPIONATE | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | AEROSOL, FOAM;TOPICAL |
1 product